MedTrace Logo

Ovarian Blockade During Fertility Preservation in Patients With Endometriosis

NCT06106919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-12-10

No results posted yet for this study

Summary

The aim of the study is to demonstrate the non-inferiority of dienogest on the number of mature oocytes collected compared with "conventional" ovarian stimulation protocols (using a GnRH agonist or antagonist), in patients with endometriosis in a fertility preservation context.

Conditions

  • Endometriosis

Interventions

OTHER

surveys (Fertiqol and WHOQOL-BREF)

surveys (Fertiqol and WHOQOL-BREF)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-18
Primary Completion
2024-04-03
Completion
2024-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06106919 on ClinicalTrials.gov